abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of C-reactive protein. The composition comprises an antisense compound, particularly an antisense oligonucleotide, targeted to a nucleic acid encoding a C-reactive protein. Methods of using these compounds are provided for modulation of C-reactive protein expression and for the treatment of diseases associated with C-reactive protein expression. |